InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

INTELLIGENT BIO SOLUTIONS INC.

INBS Clue Score55
United States Fiscal year ends June CIK 0001725430
$1.53 -2.55% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.53 −29.49% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 Dec 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue0.2Operating income−2.9Net income−3.2Fiscal year 2021Revenue2.0 +949.3%Operating income−5.6Net income−7.0Fiscal year 2022Revenue0.4 −77.9%Operating income−8.3Net income−8.3EPS, diluted−11.33Fiscal year 2023Revenue1.3 +187.5%Operating income−12.6Net income−10.6EPS, diluted−127.00Fiscal year 2024Revenue3.1 +147.6%Operating income−10.3Net income−10.2EPS, diluted−6.38Fiscal year 2025Revenue3.1 −1.9%Operating income−10.7Net income−10.6EPS, diluted−20.04Fiscal year 2026Revenue4.2 +38.1%Operating income−12.6Net income−12.4EPS, diluted−8.44
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 0.2 2.0 0.4 1.3 3.1 3.1 4.2
Growth +949.3% −77.9% +187.5% +147.6% −1.9% +38.1%
Operating income −2.9 −5.6 −8.3 −12.6 −10.3 −10.7 −12.6
Net income −3.2 −7.0 −8.3 −10.6 −10.2 −10.6 −12.4
Growth
EPS, diluted n/a n/a −11.33 −127.00 −6.38 −20.04 −8.44

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Operating margin−1,513.7%Net margin−1,676.2%Fiscal year 2021Operating margin−281.4%Net margin−355.3%Fiscal year 2022Operating margin−1,907.1%Net margin−1,900.1%Fiscal year 2023Gross margin26.0%Operating margin−1,002.1%Net margin−845.9%Fiscal year 2024Gross margin45.8%Operating margin−330.5%Net margin−326.4%Free cash flow margin−314.7%Fiscal year 2025Gross margin40.8%Operating margin−349.8%Net margin−346.2%Free cash flow margin−324.6%Fiscal year 2026Gross margin48.6%Operating margin−299.1%Net margin−294.9%Free cash flow margin−285.9%
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin n/a n/a n/a 26.0% 45.8% 40.8% 48.6%
Operating margin −1,513.7% −281.4% −1,907.1% −1,002.1% −330.5% −349.8% −299.1%
Net margin −1,676.2% −355.3% −1,900.1% −845.9% −326.4% −346.2% −294.9%
Free cash flow margin n/a n/a n/a n/a −314.7% −324.6% −285.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−0.5Fiscal year 2021Operating cash flow−11.3Fiscal year 2022Operating cash flow−3.4Fiscal year 2023Operating cash flow−7.4Fiscal year 2024Operating cash flow−9.6Capital expenditure−0.2Free cash flow−9.8Fiscal year 2025Operating cash flow−9.7Capital expenditure−0.2Free cash flow−9.9Fiscal year 2026Operating cash flow−11.9Capital expenditure−0.1Free cash flow−12.1
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −0.5 −11.3 −3.4 −7.4 −9.6 −9.7 −11.9
Capital expenditure n/a n/a n/a n/a −0.2 −0.2 −0.1
Free cash flow n/a n/a n/a n/a −9.8 −9.9 −12.1
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash0.4Shareholders’ equity−5.2Fiscal year 2021Cash12.6Shareholders’ equity15.1Fiscal year 2022Cash8.2Shareholders’ equity6.6Fiscal year 2023Cash1.5Shareholders’ equity3.8Fiscal year 2024Cash6.3Shareholders’ equity8.3Fiscal year 2025Cash1.0Shareholders’ equity3.0Fiscal year 2026Cash4.0Shareholders’ equity5.5
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 0.4 12.6 8.2 1.5 6.3 1.0 4.0
Shareholders’ equity −5.2 15.1 6.6 3.8 8.3 3.0 5.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2023† 30 Jun 2023 FY2024† 30 Jun 2024 FY2025† 30 Jun 2025 FY2026† 30 Jun 2026
Operations
−0.5 −11.3 −3.4 −7.4 −9.6 −9.7 −11.9
Growth
n/a n/a n/a 0.8 1.0 1.0 n/a
Investment
n/a n/a n/a n/a −0.2 −0.2 −0.1
calc n/a n/a n/a n/a −9.8 −9.9 −12.1
Growth
calc n/a n/a n/a n/a −6.15 −18.79 −8.18
−0.0 n/a −0.9 −0.7 −0.2 −0.2 −0.1
Financing
0.7 23.4 n/a 1.4 14.6 4.6 15.0

† The diluted share count jumps at 2023 and 2024 and 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.